1. Home
  2. DVAX vs HAS Comparison

DVAX vs HAS Comparison

Compare DVAX & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$15.40

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Hasbro Inc.

HAS

Hasbro Inc.

HOLD

Current Price

$81.81

Market Cap

11.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DVAX
HAS
Founded
1996
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
11.1B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
DVAX
HAS
Price
$15.40
$81.81
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$26.50
$88.55
AVG Volume (30 Days)
1.6M
1.7M
Earning Date
11-05-2025
10-23-2025
Dividend Yield
N/A
3.44%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$330,514,000.00
$4,357,000,000.00
Revenue This Year
$24.63
$10.26
Revenue Next Year
$15.85
$6.23
P/E Ratio
N/A
N/A
Revenue Growth
26.73
0.79
52 Week Low
$9.20
$49.00
52 Week High
$14.63
$85.15

Technical Indicators

Market Signals
Indicator
DVAX
HAS
Relative Strength Index (RSI) 89.32 54.67
Support Level $10.78 $81.00
Resistance Level $11.29 $82.51
Average True Range (ATR) 0.23 1.84
MACD 0.28 -0.19
Stochastic Oscillator 97.94 38.66

Price Performance

Historical Comparison
DVAX
HAS

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.

Share on Social Networks: